Most people taking blood thinners do not need to stop them before cataract surgery. Cataract removal by phacoemulsification, the standard technique used today, is classified as a low-bleeding-risk procedure in multiple clinical guidelines, and the evidence consistently shows that continuing antiplatelet or anticoagulant medications is safe for the vast majority of patients.1PubMed Central. Evaluation of Bleeding Risk of Cataract Phacoemulsification in Patients with Long-term Aspirin Use after Percutaneous Coronary Intervention The question, though, has more texture than a flat “keep taking your pills,” because the type of blood thinner you use, the anesthesia technique your surgeon prefers, and whether any additional procedures are being performed all shift the risk profile in ways worth understanding.
Why Cataract Surgery Is Considered Low Risk
Modern cataract surgery involves tiny incisions, usually around two to three millimeters, made through the clear cornea. These incisions are self-sealing, meaning they close on their own without stitches in most cases. The surgery takes place in the front chamber of the eye, an area with relatively limited blood supply compared to deeper structures. The combination of small wounds and a bloodless surgical field is what earns cataract phacoemulsification its low-risk classification. When performed under topical anesthesia (numbing eye drops rather than injections around the eye), there is even less opportunity for a blood thinner to cause trouble, because no needle passes near the blood vessels behind the eye.
That low-risk status has been reinforced by review articles spanning ophthalmology, cardiology, and anesthesiology. A review of perioperative anticoagulant management across eye surgeries concluded that the vast majority of ocular surgeries, including cataract surgery, can be safely performed without stopping antiplatelet or anticoagulant therapy.2PubMed Central. Perioperative Management of Anticoagulants in Ocular Surgeries A Spanish ophthalmological review put it more precisely: the only firm recommendation for maintaining antithrombotic drugs applies to cataract surgery using phacoemulsification with topical anesthesia.3Archivos de la Sociedad Española de OftalmologÃa (English Edition). Review Update on the perioperative management of antiplatelets and anticoagulants in ophthalmic surgery In other words, for standard cataract surgery done with drops, the evidence is about as clear as it gets in medicine.
Aspirin and Cataract Surgery
Aspirin is the blood thinner most commonly used by cataract patients, many of whom take it daily for heart protection. A large meta-analysis pooling data from more than 65,000 subjects found that continuing aspirin does raise the chance of one specific complication: subconjunctival hemorrhage, which is bleeding under the thin membrane covering the white of the eye. The risk was about 74% higher in aspirin users compared to those who stopped or never took it.4PubMed. Do We Need to Hold Aspirin Before Cataract Surgery? A Systematic Review and Meta-Analysis of 65,196 Subjects That sounds alarming until you learn what subconjunctival hemorrhage actually is: a painless red blotch on the white of the eye that looks dramatic but resolves on its own, usually within a week or two. It does not affect vision.
The same meta-analysis found no significant difference between aspirin users and non-users for any of the complications that actually threaten sight, including bleeding inside the eye, pressure spikes, corneal swelling, or changes in visual acuity.4PubMed. Do We Need to Hold Aspirin Before Cataract Surgery? A Systematic Review and Meta-Analysis of 65,196 Subjects A separate comparative study echoed this pattern: subconjunctival hemorrhage was more common in the group that kept taking their medications (about 17% versus 11%), but no patient in either group experienced significant intraoperative bleeding.5PubMed. Evaluation of the need to discontinue antiplatelet and anticoagulant medications before cataract surgery The bottom line for aspirin: you may end up with a bloodshot-looking eye for a few days, but your vision will not be affected.
Warfarin and Cataract Surgery
Warfarin is a stronger anticoagulant than aspirin, and it requires regular blood monitoring to keep its effect in a safe range (measured by something called the INR). Patients and doctors are sometimes more cautious about continuing warfarin than aspirin, but the evidence here is reassuring too. A systematic review and meta-analysis found that patients who continued warfarin did have roughly three times the odds of bleeding compared to those who stopped.6PubMed. Safety of continuing warfarin therapy during cataract surgery: a systematic review and meta-analysis That sounds like a lot, but “three times a tiny number” is still a tiny number. The overall incidence of bleeding in warfarin users was around 10%, and nearly all of those events were self-limiting: small spots of blood in the eye or under the conjunctiva that resolved without treatment. No patient in the review had compromised visual acuity because of a bleeding event.6PubMed. Safety of continuing warfarin therapy during cataract surgery: a systematic review and meta-analysis
One study of warfarin users undergoing cataract surgery under topical anesthesia, with an average INR of about 2.0 (well within the standard therapeutic range), reported zero intracameral bleeding during the procedure and zero postoperative hemorrhagic complications in either the warfarin group or the control group.7Arquivos Brasileiros de Oftalmologia. Safety of warfarin therapy during cataract surgery under topical anesthesia The takeaway is that warfarin users whose INR is in the therapeutic range can safely proceed with surgery. If your INR has been unstable or is significantly above range, your surgeon may want a recent blood test to confirm it is not dangerously high before going ahead.
Newer Anticoagulants (DOACs)
Direct oral anticoagulants such as rivaroxaban, apixaban, dabigatran, and edoxaban have largely replaced warfarin for many patients because they do not require regular blood monitoring. Data on these drugs and cataract surgery, while still growing, points in the same direction as the warfarin evidence. A study comparing patients on DOACs to a control group without anticoagulation found no significant difference in either intraoperative or postoperative bleeding. Hemorrhagic complications occurred in about 4% of the DOAC group and 3% of the control group, a gap well within the range of chance.8PubMed Central. Effect of direct oral anticoagulants on bleeding during and after cataract surgery
A smaller study of 25 patients on DOACs who underwent phacoemulsification under topical anesthesia found that minor conjunctival bleeding at the incision site occurred in a handful of eyes during surgery, but no intraocular bleeding was observed and no hemorrhagic complications appeared at the one-week follow-up. Importantly, blood tests confirmed that 85% of those patients were at full therapeutic levels of their medication at the time of surgery.9PubMed. Safety of cataract surgery in patients treated with the new oral anticoagulants (NOACs) Another study went further, comparing patients who continued their DOAC with those who temporarily stopped it. There was no significant difference in complications between the two groups, and interestingly, the only patients who developed bruising and subconjunctival hemorrhage were in the group that had withheld the drug and received a retrobulbar injection (anesthesia behind the eye).10PubMed. Phacoemulsification cataract surgery in patients receiving novel oral anticoagulant medications That finding highlights how the choice of anesthesia technique can matter more than the blood thinner itself.
Dual Antiplatelet Therapy
Some patients take two antiplatelet drugs at the same time, typically aspirin plus clopidogrel, after a coronary stent placement or heart attack. This combination carries a higher bleeding risk in general surgery, and stopping it prematurely can be dangerous because of the risk of stent clot formation. For cataract surgery specifically, a study of patients on dual antiplatelet therapy found no significant difference in hemorrhagic or non-hemorrhagic complications compared to a control group. No surgery had to be postponed or cancelled because of bleeding, no cases of bleeding inside the eye occurred, and no cardiovascular events happened during follow-up.11PubMed. Combined aspirin and clopidogrel therapy in phacoemulsification cataract surgery: a risk factor for ocular hemorrhage? For patients who have been told never to stop their dual therapy without cardiologist approval, this is especially reassuring.
The Real Danger of Stopping
The reason most guidelines lean heavily toward continuing blood thinners is not just that the bleeding risk from surgery is low. It is that the risk of stopping can be genuinely life-threatening. Blood thinners are prescribed because the patient has a condition that makes dangerous clots likely: atrial fibrillation, mechanical heart valves, recent stent placement, a history of stroke or deep vein thrombosis. Interrupting the medication, even briefly, reopens the window for those clots to form.
A large study tracking outcomes around cataract surgery found that routine users of aspirin or warfarin who continued their medications had thromboembolic event rates (stroke, transient ischemic attack, or deep vein thrombosis) of roughly 4 per 1,000 surgeries. Among those who discontinued aspirin, the rate was about 1 per 1,000, but the confidence interval was wide enough that the difference could easily be due to chance. Heart attacks or episodes of cardiac ischemia occurred at rates of about 5 per 1,000 surgeries in continuous aspirin users and about 8 per 1,000 in continuous warfarin users, with no clear difference between those who continued and those who stopped.12PubMed. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery These numbers are small in absolute terms, but a stroke or heart attack is a catastrophically different outcome from a self-resolving red spot on the eye.
There is also a subtler biological concern. When certain anticoagulants, particularly DOACs, are abruptly stopped, the body’s clotting system can temporarily rebound to a state that is actually more clot-prone than it was before the medication was started. Research suggests this happens because the drug’s suppression of thrombin (a key clotting protein) leads to a gradual decline in the body’s own natural anticoagulants, such as protein C and protein S. When the drug is removed, thrombin generation surges while those natural brakes are still depleted, creating a brief but real window of heightened clotting risk.13PubMed Central. Prothrombotic Rebound After Discontinuation of Direct Oral Anticoagulants Therapy: A Systematic Review This rebound effect makes stopping and restarting anticoagulants for a low-risk procedure like cataract surgery an especially poor trade-off.
When the Answer Gets More Complicated
The strong “keep taking your medication” advice applies to standard, uncomplicated phacoemulsification performed under topical (drop-based) anesthesia. Several factors can shift the calculus.
Anesthesia type matters. If your surgeon uses a retrobulbar or peribulbar injection to numb the eye, a needle passes through tissue that contains blood vessels. A blood thinner raises the small but real risk of a retrobulbar hemorrhage, which is bleeding behind the eye that can compress the optic nerve. Some clinicians worry more about antithrombotics in this setting than they do for topical anesthesia, which involves no injection at all.14BJA: British Journal of Anaesthesia. Stopping antithrombotics during regional anaesthesia and eye surgery: crying wolf? If your surgeon prefers injection-based anesthesia, the discussion about your blood thinners becomes more individualized.
Combined procedures change the picture too. If your cataract surgery includes a minimally invasive glaucoma procedure at the same time, the bleeding concern depends on which type of glaucoma device or technique is used. A survey of glaucoma surgeons found that most do not stop antiplatelet or anticoagulant agents before implanting small drainage devices like the iStent or Hydrus, which are placed through the same tiny incision used for cataract surgery. But for techniques that involve cutting or removing tissue from the eye’s drainage angle, nearly half of surgeons reported high concern about bleeding, and anticoagulants were held more often for those procedures.15PubMed Central. Anticoagulation for Minimally Invasive Glaucoma Surgery: An American Glaucoma Society Survey If you are having a combined cataract-glaucoma procedure, ask your surgeon specifically about the glaucoma component.
An extremely rare but serious complication called suprachoroidal hemorrhage, bleeding underneath the deepest layer of the eye, occurs in roughly 1 in 3,500 cataract operations. The strongest risk factor by far is a surgical complication called posterior capsule rupture, which increases the odds by about 18-fold. Age above 90, elevated eye pressure, and glaucoma also raise the risk.16Nature. The Royal College of Ophthalmologists’ National Ophthalmology Database Study of Cataract Surgery: Report 12, Risk factors for suprachoroidal haemorrhage during cataract surgery Blood thinners are not the primary driver of this complication, but in very high-risk patients (say, someone over 90 with glaucoma and elevated eye pressure), the surgeon may weigh the decision more carefully.
Who Should Be Making This Decision
One persistent problem in practice is that patients sometimes stop their blood thinners on their own before surgery, or a well-meaning but under-informed provider tells them to stop without coordinating with the doctor who prescribed the medication. This can be dangerous. The decision involves weighing your specific thromboembolic risk (why are you on the drug, how high is your clot risk if you stop) against your specific bleeding risk (what kind of surgery, what anesthesia, what other eye conditions you have). That calculus requires input from both the eye surgeon and the physician managing your blood thinner, whether that is your cardiologist, neurologist, or primary care doctor.17Current Opinion in Ophthalmology. Perioperative management of anticoagulants and antiplatelet agents in oculoplastic surgery
If your eye surgeon tells you to stop your blood thinner, ask whether they have discussed it with the doctor who prescribed it. If your cardiologist tells you to stop it “just to be safe” before cataract surgery, it is worth mentioning that current evidence supports continuation for standard phacoemulsification. The goal is to make sure someone has looked at both sides of the equation for your specific situation, rather than applying a blanket rule in either direction.
What to Expect If You Continue Your Medication
If you go into cataract surgery while still on a blood thinner, a few things are more likely but none of them are cause for alarm. You have a modestly higher chance of a subconjunctival hemorrhage, the cosmetically unpleasant but harmless red patch on the white of your eye. You might see a small amount of blood in the eye immediately after surgery that clears within days. Your surgeon may take a little extra time cauterizing small vessels during the procedure. None of these things typically affect the outcome of the surgery or your final vision.
What you should not expect is a significantly higher risk of vision-threatening complications. Across all the major drug categories studied, from aspirin alone to dual antiplatelet therapy to warfarin to newer oral anticoagulants, the consistent finding is that vision outcomes are the same whether you continue or stop. The minor cosmetic bleeding events are the price of keeping yourself protected against stroke and heart attack during the perioperative period, and by any reasonable measure, that is a trade-off worth making.
Herbal Supplements and Over-the-Counter Blood Thinners
Patients often focus on their prescription blood thinners and forget to mention supplements that also affect bleeding. Fish oil at high doses, vitamin E supplements, ginkgo biloba, garlic extract, and turmeric or curcumin can all have mild antiplatelet or anticoagulant effects. The evidence on these supplements and cataract surgery is far thinner than for prescription medications, but the general principle holds: cataract surgery is low risk enough that these supplements are unlikely to cause meaningful problems. Still, mention everything you take to your surgical team so they have the full picture. Some surgeons ask patients to stop high-dose fish oil a week before surgery as a precaution, while others do not. Either approach is reasonable given the small magnitude of the risk involved.